Clinical Trials Logo

Brain Injuries clinical trials

View clinical trials related to Brain Injuries.

Filter by:

NCT ID: NCT02893345 Active, not recruiting - Clinical trials for Brain Injuries, Traumatic

Safe@Home: A Self-Management Program for Individuals With TBI and Their Families

Start date: August 8, 2015
Phase: Phase 2
Study type: Interventional

People who sustain moderate to severe traumatic brain injury (TBI) have an increased risk for unintentional injury and harm when resuming day to day activities in the home and community. People who sustain brain injuries primarily want to independently do the activities they enjoy while families primarily focus on avoiding injury or other harm events. Safe@Home is an injury prevention education and activity training program. Participants who have sustained a moderate or severe TBI receive a personalized strengths and safety risk assessment, tailored injury prevention education, and in-home training with a transition coach on self-selected activities. This study will evaluate whether the Safe@Home program reduces injuries and harm and increases clients' independence in their everyday activities in the home and community compared to a usual care control group.

NCT ID: NCT02891941 Terminated - Clinical trials for Traumatic Brain Injury

Neuroimaging & Plasma Markers for Predicting Outcomes After Mild Traumatic Brain Injury

Start date: June 2013
Phase: N/A
Study type: Observational [Patient Registry]

This exploratory study aims to identify the most promising biomarkers that alone or in combination might predict development of mood disorders [i.e., major depression (MD], cognitive disorders [i.e., executive function deficits (EFD)], and functional impairment following repetitive/mild traumatic brain injury (MTBI).

NCT ID: NCT02891421 Completed - Clinical trials for Traumatic Brain Injury

Therapeutic Horsemanship in Veterans

Start date: May 2013
Phase: N/A
Study type: Interventional

The project partnered with U.S. military veterans with a premier accredited therapeutic riding center for six weeks. The veterans interacted with horses by grooming and learning about them, as well as riding them for one hour per week during which they gained a variety of skills. We hoped the veterans would experience a reduction in Post Traumatic Stress Disorder (PTSD) symptoms, depression, and loneliness, while improving their social and emotional health and self-efficacy.

NCT ID: NCT02889289 Completed - Clinical trials for Traumatic Brain Injury

Using the Xbox Kinect for Chronic TBI

Start date: May 2015
Phase: N/A
Study type: Interventional

This study will evaluate the potential for improving balance for a single individual with a history of traumatic brain injury (TBI). The participant will engage in supervised therapy using commercial games on the Xbox Kinect. This study will also evaluate the viability of improving cardiovascular fitness using this intervention as well. The investigators hypothesize that balance improvements will occur and that using the Xbox Kinect is a viable way of improving cardiovascular fitness.

NCT ID: NCT02881151 Completed - Clinical trials for TBI (Traumatic Brain Injury)

Deep Brain Stimulation for the Treatment of Traumatic Brain Injury

Start date: April 20, 2017
Phase: N/A
Study type: Interventional

This study involves the treatment of cognitive impairment secondary to moderate to severe brain injury using central thalamic deep brain stimulation. Although all patients will receive stimulation continuously through a surgically implanted pacemaker-like device, half of the patients will have the device deactivated during a blinded assessment phase. The device will be reactivated following this assessment and patients will have the option to continue stimulation in an open-label continuation.

NCT ID: NCT02878577 Completed - Clinical trials for Traumatic Brain Injury (TBI)

Monitoring the Alterations That Occur in the Brain Following Traumatic Brain Injury

TBI
Start date: September 21, 2016
Phase:
Study type: Observational

This project, will combine the data collected from existing and innovative technologies: fMRI scans, mapping brain connectivity using EEG in combination with eye-tracking technology (the BNA technology developed by ELMINDA), characterizing of cortical layers using magnetic resonance (the CoLI technology developed by Tel-Aviv University), and DTI imaging (imaging of brain tracks). To do so, Sheba's Medical Center, Tel Hashomer, joined the project and is responsible for recruiting patients from the Department of Neurosurgery and Department of Rehabilitation and also is responsible for performing the needed tests.

NCT ID: NCT02874027 Recruiting - Clinical trials for Traumatic Brain Injury With Brief Loss of Consciousness

The Clinical Research on the Relationship Between Depression and Gut Microbiota in TBI Patients

Start date: August 2016
Phase: N/A
Study type: Observational

Microbiome studies may be highlighted as crucial in the development of depression for TBI patients. The microbiota-gut-brain connection may further provide an opportunity for microbiota manipulation to treat the TBI patients with depression.This study is to investigate whether exist the relationship between depression and circadian rhythm of patients with TBI or not and focus the study on the potential of the host-microbiota interaction in regulating depression.

NCT ID: NCT02868684 Completed - Clinical trials for Posttraumatic Stress Disorder

Imaging Biomarkers of Mild Traumatic Brain Injury: a Longitudinal Cohort Study

Start date: August 2016
Phase:
Study type: Observational

This longitudinal cohort study aims to detect the topographical nature of the white matter microstructure and resting state functional connectivity patterns across the whole brain in the evolution of pathology as a function of time following mild TBI. All consecutively patients with the non-contrast head CT because of acute head trauma from the local emergency department (ED) formed the initial population of this study. Age, sex, education-level matched healthy controls will also be enrolled. The initial scan will performed within 7 days post-injury. Clinical assessment was performed within 24 hours of MR imaging and included a broad neuropsychological and symptom assessments. Follow-up examination will conduct at 1 month, 3 month, 6-12 months.

NCT ID: NCT02868671 Completed - Clinical trials for Mild Traumatic Brain Injury

Acupuncture for Mild Traumatic Brain Injury:A Functional Magnetic Resonance Imaging Study

Start date: August 2016
Phase: N/A
Study type: Interventional

The overall goal of this study is to examine if acupuncture intervention can reduce the post-concussion symptom (PCS), and affective and cognitive complaints among mild traumatic brain injury (TBI). This study also hypothesized that compared to those in the sham acupuncture and waiting list control groups, patients in the real acupuncture group will have fewer symptoms of depression, sleep problems and post-concussion symptoms.

NCT ID: NCT02867137 Completed - Clinical trials for Traumatic Brain Injury

Biomarkers in Prehospital Rule-out of Intracranial Lesions in TBI Patients

PreTBI I
Start date: February 15, 2017
Phase:
Study type: Observational

The PreTBI I study will investigate whether prehospital blood samples drawn already in the ambulance can rule-out intracranial lesions in patients suffering head trauma. The study aims to improve triage and treatment of patients suffering mild head trauma, who are considered low-risk patients. These patients do not always benefit from hospitalization, but are nevertheless admitted on precaution, as clinical assesment can be difficult. Hypotheses: 1. A prehospital measurement of serum S100B ≤ 0,10 microgram/L in mild TBI patients rules out traumatic intracranial lesion with a sensitivity >97%. 2. A prehospital measurement of serum GFAP (glial acidic fibrillary protein) in mild TBI patients rules out traumatic intracranial lesion with sensitivity >97% and results in lower false positive rate than S100B. 3. Prehospital measurements of both GFAP and S100B results in lower false positive rates than in-hospital measurements.